Cytokinetics, Incorporated (CYTK): Price and Financial Metrics
CYTK Price/Volume Stats
| Current price | $49.86 | 52-week high | $110.25 |
| Prev. close | $51.09 | 52-week low | $30.68 |
| Day low | $49.65 | Volume | 1,570,900 |
| Day high | $50.95 | Avg. volume | 2,057,156 |
| 50-day MA | $53.86 | Dividend yield | N/A |
| 200-day MA | $59.68 | Market Cap | 5.88B |
CYTK Stock Price Chart Interactive Chart >
Cytokinetics, Incorporated (CYTK) Company Bio
Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. The company was founded in 1997 and is based in South San Francisco, California.
CYTK Price Returns
| 1-mo | -9.25% |
| 3-mo | -13.01% |
| 6-mo | 3.23% |
| 1-year | 56.25% |
| 3-year | 21.91% |
| 5-year | 417.22% |
| YTD | -40.28% |
| 2023 | 82.21% |
| 2022 | 0.53% |
| 2021 | 119.35% |
| 2020 | 95.85% |
| 2019 | 67.88% |
Continue Researching CYTK
Want to see what other sources are saying about Cytokinetics Inc's financials and stock price? Try the links below:Cytokinetics Inc (CYTK) Stock Price | Nasdaq
Cytokinetics Inc (CYTK) Stock Quote, History and News - Yahoo Finance
Cytokinetics Inc (CYTK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...